Ultragenyx Pharmaceutical | RARE - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 -1.04 -1.81 Nov/04
FY2026Q2 Jun/2026 -0.90 -1.23 -1.17 Aug/04
FY2026Q1 Mar/2026 -1.84 -1.43 -1.57 May/05
FY2025Q4 Dec/2025 -1.29 -1.17 -1.39 Feb/12
FY2025Q3 Sep/2025 -1.81 -1.23 -1.40 Nov/04




Eps Alterar Data
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Immunic USD -0.1 0.03 2025-12
Insmed USD -0.06 0.7 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Karyopharm Therapeutics USD -1.02 1.2 2026-03
Kyowa Hakko Kirin JPY 35.49 12.5 2026-06
MacroGenics USD -0.58 0.36 2026-03
Moderna USD -1.97 1.43 2026-06
Neurocrine Biosciences USD 2.85 0.91 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06